RU2017128643A - Новое производное хинолина для применения в лечении и профилактике вирусных инфекций - Google Patents
Новое производное хинолина для применения в лечении и профилактике вирусных инфекций Download PDFInfo
- Publication number
- RU2017128643A RU2017128643A RU2017128643A RU2017128643A RU2017128643A RU 2017128643 A RU2017128643 A RU 2017128643A RU 2017128643 A RU2017128643 A RU 2017128643A RU 2017128643 A RU2017128643 A RU 2017128643A RU 2017128643 A RU2017128643 A RU 2017128643A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutically acceptable
- quinoline derivative
- acceptable salts
- formula
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (17)
1. Производное хинолина формулы (1)
или одна из его фармацевтически приемлемых солей.
2. Производное хинолина по п. 1 или одна из его фармацевтически приемлемых солей для применения в качестве лекарственного средства.
3. Формула (1) хинолина по п. 1 или одна из его фармацевтически приемлемых солей для применения при лечении или профилактике вирусной или ретровирусной инфекции и, в частности, СПИДа или связанного со СПИДом состояния или вируса иммунодефицита человека (ВИЧ).
4. Фармацевтическая композиция, содержащая производное хинолина по п. 1 или одну из его фармацевтически приемлемых солей и по меньшей мере один фармацевтически приемлемый эксципиент.
5. Лекарственное средство, содержащее производное хинолина по п. 1 или одну из его фармацевтически приемлемых солей.
6. Способ получения производного хинолина по п. 1, включающий стадию обработки соединения(4)
в растворе гидропероксида лития, например, в растворителе, таком как тетрагидрофуран или диоксин, которой необязательно предшествует стадия получения соединения (4), состоящая во взаимодействии соединения формулы (2)
с соединением формулы (3)
в присутствии соли тяжелого металла, такой как соль кадмия, например карбоната кадмия, в частности, в растворителе, таком как нитрометан, обычно при температуре кипения растворителя.
7. Соединение формулы (4)
или одна из его фармацевтически приемлемых солей.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15305274.1A EP3059236A1 (en) | 2015-02-23 | 2015-02-23 | A new quinoline derivative for use in the treatment and prevention of viral infections |
EP15305274.1 | 2015-02-23 | ||
PCT/EP2016/053532 WO2016135052A1 (en) | 2015-02-23 | 2016-02-19 | A new quinoline derivative for use in the treatment and prevention of viral infections |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017128643A true RU2017128643A (ru) | 2019-03-25 |
RU2017128643A3 RU2017128643A3 (ru) | 2019-04-15 |
RU2723013C2 RU2723013C2 (ru) | 2020-06-08 |
Family
ID=52629497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017128643A RU2723013C2 (ru) | 2015-02-23 | 2016-02-19 | Новое производное хинолина для применения в лечении и профилактике вирусных инфекций |
Country Status (22)
Country | Link |
---|---|
US (1) | US10329317B2 (ru) |
EP (2) | EP3059236A1 (ru) |
JP (1) | JP6797126B2 (ru) |
KR (1) | KR102583506B1 (ru) |
CN (1) | CN107531681B (ru) |
AU (1) | AU2016223687B2 (ru) |
BR (1) | BR112017017500B1 (ru) |
CA (1) | CA2975577C (ru) |
CU (1) | CU24525B1 (ru) |
DK (1) | DK3262037T3 (ru) |
ES (1) | ES2785374T3 (ru) |
HR (1) | HRP20200649T1 (ru) |
HU (1) | HUE048577T2 (ru) |
LT (1) | LT3262037T (ru) |
MX (1) | MX2017010506A (ru) |
PL (1) | PL3262037T3 (ru) |
PT (1) | PT3262037T (ru) |
RS (1) | RS60369B1 (ru) |
RU (1) | RU2723013C2 (ru) |
SI (1) | SI3262037T1 (ru) |
WO (1) | WO2016135052A1 (ru) |
ZA (1) | ZA201705633B (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2757161A1 (en) | 2013-01-17 | 2014-07-23 | Splicos | miRNA-124 as a biomarker of viral infection |
EP2974729A1 (en) | 2014-07-17 | 2016-01-20 | Abivax | Quinoline derivatives for use in the treatment of inflammatory diseases |
EP3059591A1 (en) | 2015-02-23 | 2016-08-24 | Abivax | Methods for screening compounds for treating or preventing a viral infection or a virus-related condition |
US20190034990A1 (en) * | 2017-07-26 | 2019-01-31 | International Business Machines Corporation | Information insight system for providers of products or services |
EP3669874A1 (en) * | 2018-12-20 | 2020-06-24 | Abivax | Quinoline derivatives for use in the treatment or prevention of cancer |
EP3669873A1 (en) | 2018-12-20 | 2020-06-24 | Abivax | Quinoline derivatives for use ine the traeatment of inflammation diseases |
EP3884946A1 (en) * | 2020-03-25 | 2021-09-29 | Abivax | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
EP3881844A1 (en) * | 2020-03-20 | 2021-09-22 | Abivax | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
CA3172179A1 (en) * | 2020-03-20 | 2021-09-23 | Jamal Tazi | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
CN117222639A (zh) | 2021-05-27 | 2023-12-12 | 江苏恒瑞医药股份有限公司 | 喹啉胺类化合物、其制备方法及其在医药上的应用 |
EP4201948A1 (en) | 2021-12-21 | 2023-06-28 | Abivax | Method of preparation of 1-(n-(quinolin-2-yl)-(phenylamino)-1-deoxy-beta-d-glucopyranuronic acid derivatives |
EP4212156A1 (en) | 2022-01-13 | 2023-07-19 | Abivax | Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator |
EP4215196A1 (en) * | 2022-01-24 | 2023-07-26 | Abivax | Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a jak inhibitor |
WO2024109936A1 (zh) * | 2022-11-25 | 2024-05-30 | 江苏恒瑞医药股份有限公司 | 一种喹啉胺类化合物晶型及其制备方法 |
WO2024109937A1 (zh) * | 2022-11-25 | 2024-05-30 | 江苏恒瑞医药股份有限公司 | 一种喹啉胺类化合物的可药用盐、晶型及其制备方法 |
CN116617226B (zh) * | 2023-06-21 | 2024-06-25 | 湖北工业大学 | 新型吲哚喹啉衍生物作为肠道病毒71型抑制剂的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2436786A1 (fr) | 1978-09-21 | 1980-04-18 | Anvar | Nouveaux derives des pyrido (4,3-b) carbazoles (ellipticines), substitues en position 1 par une chaine polyaminee, leur obtention et leur application a titre de medicaments |
FR2627493B1 (fr) | 1988-02-23 | 1991-10-31 | Sanofi Sa | Procede de preparation de derives d'isoquinoleine |
FR2645861A1 (fr) | 1989-04-17 | 1990-10-19 | Inst Nat Sante Rech Med | Utilisation de dipyrido (4,3-b) (3,4-f) indoles pour la preparation de medicaments utiles pour le traitement du sida |
US5354853A (en) * | 1993-03-12 | 1994-10-11 | Genzyme Corporation | Phospholipid-saccharide conjugates |
FR2859474B1 (fr) | 2003-09-04 | 2006-01-13 | Centre Nat Rech Scient | Utilisation de composes derives d'indole pour la preparation d'un medicament utile pour le traitement de maladies genetiques resultant de l'alteration des processus d'epissage |
CU24461B1 (es) * | 2009-06-12 | 2020-01-03 | Abivax | Compuestos útiles para tratar envejecimiento prematuro y en particular progeria |
EP2465502A1 (en) | 2010-12-15 | 2012-06-20 | Société Splicos | Compounds useful for treating AIDS |
BR112016000127B1 (pt) * | 2013-07-05 | 2022-02-15 | Abivax | Compostos bicíclicos úteis para tratar doenças causadas por retrovírus |
EP2975034A1 (en) | 2014-07-17 | 2016-01-20 | Abivax | A quinoline derivative for the treatment of inflammatory diseases and AIDS |
EP2974729A1 (en) | 2014-07-17 | 2016-01-20 | Abivax | Quinoline derivatives for use in the treatment of inflammatory diseases |
-
2015
- 2015-02-23 EP EP15305274.1A patent/EP3059236A1/en not_active Withdrawn
-
2016
- 2016-02-19 RS RS20200447A patent/RS60369B1/sr unknown
- 2016-02-19 MX MX2017010506A patent/MX2017010506A/es unknown
- 2016-02-19 WO PCT/EP2016/053532 patent/WO2016135052A1/en active Application Filing
- 2016-02-19 JP JP2017543995A patent/JP6797126B2/ja active Active
- 2016-02-19 BR BR112017017500-2A patent/BR112017017500B1/pt active IP Right Grant
- 2016-02-19 CN CN201680011519.7A patent/CN107531681B/zh active Active
- 2016-02-19 RU RU2017128643A patent/RU2723013C2/ru active
- 2016-02-19 US US15/552,587 patent/US10329317B2/en active Active
- 2016-02-19 PT PT167055151T patent/PT3262037T/pt unknown
- 2016-02-19 LT LTEP16705515.1T patent/LT3262037T/lt unknown
- 2016-02-19 ES ES16705515T patent/ES2785374T3/es active Active
- 2016-02-19 EP EP16705515.1A patent/EP3262037B1/en active Active
- 2016-02-19 AU AU2016223687A patent/AU2016223687B2/en active Active
- 2016-02-19 KR KR1020177023445A patent/KR102583506B1/ko active IP Right Grant
- 2016-02-19 DK DK16705515.1T patent/DK3262037T3/da active
- 2016-02-19 CU CU2017000109A patent/CU24525B1/es unknown
- 2016-02-19 SI SI201630722T patent/SI3262037T1/sl unknown
- 2016-02-19 PL PL16705515T patent/PL3262037T3/pl unknown
- 2016-02-19 CA CA2975577A patent/CA2975577C/en active Active
- 2016-02-19 HU HUE16705515A patent/HUE048577T2/hu unknown
-
2017
- 2017-08-18 ZA ZA2017/05633A patent/ZA201705633B/en unknown
-
2020
- 2020-04-22 HR HRP20200649TT patent/HRP20200649T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2016223687B2 (en) | 2020-03-19 |
KR102583506B1 (ko) | 2023-09-26 |
US10329317B2 (en) | 2019-06-25 |
HUE048577T2 (hu) | 2020-07-28 |
DK3262037T3 (da) | 2020-05-04 |
CN107531681B (zh) | 2020-11-24 |
US20180030078A1 (en) | 2018-02-01 |
RU2017128643A3 (ru) | 2019-04-15 |
SI3262037T1 (sl) | 2020-09-30 |
AU2016223687A1 (en) | 2017-08-31 |
EP3262037A1 (en) | 2018-01-03 |
PL3262037T3 (pl) | 2020-10-19 |
CN107531681A (zh) | 2018-01-02 |
BR112017017500B1 (pt) | 2023-04-04 |
JP6797126B2 (ja) | 2020-12-09 |
ES2785374T3 (es) | 2020-10-06 |
RS60369B1 (sr) | 2020-07-31 |
CU24525B1 (es) | 2021-06-08 |
CA2975577C (en) | 2020-04-07 |
MX2017010506A (es) | 2017-11-13 |
PT3262037T (pt) | 2020-04-09 |
RU2723013C2 (ru) | 2020-06-08 |
WO2016135052A1 (en) | 2016-09-01 |
CA2975577A1 (en) | 2016-09-01 |
EP3059236A1 (en) | 2016-08-24 |
HRP20200649T1 (hr) | 2020-10-16 |
LT3262037T (lt) | 2020-07-10 |
KR20170129698A (ko) | 2017-11-27 |
EP3262037B1 (en) | 2020-02-12 |
CU20170109A7 (es) | 2018-02-08 |
BR112017017500A2 (pt) | 2018-04-17 |
ZA201705633B (en) | 2018-12-19 |
JP2018507215A (ja) | 2018-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2017128643A (ru) | Новое производное хинолина для применения в лечении и профилактике вирусных инфекций | |
EA201791872A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
EA201791019A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
EP3954679A3 (en) | Amide compounds for the treatment of hiv infections | |
PH12019500335A1 (en) | Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection | |
EA201890200A1 (ru) | Производные циклизированного сульфамоилариламида и их применение в качестве лекарственных препаратов для лечения гепатита b | |
EA201891876A1 (ru) | Тетрациклические пиридоновые соединения в качестве противовирусных средств | |
PH12017501258B1 (en) | Pyrazine compounds for the treatment of infectious diseases | |
NZ631762A (en) | 5-membered heteroaryls and their use as antiviral agents | |
UY35263A (es) | Compuestos terapéuticos | |
EA201591027A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
MX368110B (es) | Procedimiento para la preparacion de n-[(3-aminooxetan-3-il)metil] -2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepin-4-il)-6-metil-quinazo lin-4-amina. | |
PE20141328A1 (es) | Tenofovir alafenamida hemifumarato | |
EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
RU2017103656A (ru) | Производные изоиндолинона, полезные в качестве противовирусных средств | |
JP2015506363A5 (ru) | ||
EA201891814A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ВИЧ И СПИДа | |
EA201790495A1 (ru) | Фармацевтические композиции длительного действия | |
MX2019011220A (es) | Compuesto de pirrolopiridina novedoso, metodo de preparacion del mismo y uso del mismo. | |
WO2014124092A3 (en) | Lamivudine crystalline salts | |
TH174304A (th) | สารประกอบโพลีไซคลิก-คาร์บาโมอิลไพริโดน และ การใช้ทางเภสัชกรรมของสารนี้ | |
TH180428A (th) | องค์ประกอบของเซนิคริไวรอคและวิธีการสำหรับการผลิตและการใช้สิ่งดังกล่าว | |
AR109364A1 (es) | Compuestos antivirales | |
TH1801000823A (th) | อนุพันธ์ 5-(n-เบนซิลเตตราไฮโดรไอโซควิโนลิน-6-อิล) ไพริดิน-3-อิลอะซีติกแอซิดที่เป็นสารยับยั้ง ของการเรพลิเคชั่นของไวรัสที่มีการบกพร่องทางภูมิคุ้มกันของมนุษย์ | |
RU2013108055A (ru) | Противовирусные гетероциклические соединения |